alagebrium has been researched along with Hypertrophy, Left Ventricular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burns, WC; Burrell, LM; Candido, R; Cooper, ME; Dean, RG; Forbes, JM; Ritchie, RH; Thallas, V; Thomas, MC; Tikellis, C; Twigg, SM | 1 |
Kass, DA | 1 |
Foiles, P; Founds, H; Vasan, S | 1 |
1 review(s) available for alagebrium and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
Topics: Aging; Animals; Clinical Trials as Topic; Cross-Linking Reagents; Diabetes Mellitus; Diastole; Drug Evaluation, Preclinical; Elasticity; Glycation End Products, Advanced; Guanidines; Humans; Hypertrophy, Left Ventricular; Molecular Structure; Myocardium; Proteins; Skin; Thiazoles | 2003 |
2 other study(ies) available for alagebrium and Hypertrophy, Left Ventricular
Article | Year |
---|---|
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
Topics: Animals; Blood Pressure; Body Weight; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Male; Myocardium; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles | 2003 |
Getting better without AGE: new insights into the diabetic heart.
Topics: Animals; Collagen; Cytokines; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glycation End Products, Advanced; Heart Ventricles; Hypertrophy, Left Ventricular; Natriuretic Peptide, Brain; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles | 2003 |